Saima Sultana

Saima Sultana

Auto-generated profile, based on publicly available information

Saima Sultana

Affiliations School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, Women’s, Children’s and Adolescents’ Health Program, Burnet Institute, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2025 in Journal of Global Health
Verified
Journal Article
Open access
SSSaima Sultana
Saima Sultana
SHSayaka Horiuchi
Sayaka Horiuchi
CHCaroline Se Homer
Caroline Se Homer
ABAbdullah H. Baqui
Abdullah H. Baqui
JVJoshua P Vogel
Joshua P Vogel
The World Health Organization (WHO) defines preterm birth as occurring before 37 completed weeks of gestation or fewer than 259 days since the first day of a woman’s last menstrual period [1]. Globally, an estimated 13.4 million neonates are born preterm each year, with over 80% of these births occurring in sub-Saharan Africa and South […]

13 September 2024 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
JGJoshua F Ginnane
Joshua F Ginnane
SASamia Aziz
Samia Aziz
SSSaima Sultana
Saima Sultana
CAConnor Luke Allen
Connor Luke Allen
AMAnnie McDougall
Annie McDougall
JVJoshua P Vogel
Joshua P Vogel
Background: Postpartum haemorrhage (PPH) is an obstetric emergency. While PPH-related deaths are relatively rare in high-resource settings, PPH continues to be the leading cause of maternal mortality in limited-resource settings. We undertook a systematic review to identify, assess, and synthesise cost-effectiveness evidence on postpartum interventions to prevent, diagnose, or treat PPH. Methods and findings: This systematic review was prospectively registered on PROSPERO (CRD42023438424). We searched Medline, Embase, NHS Economic Evaluation Database (NHS EED), EconLit, CINAHL, Emcare, Web of Science, and Global Index Medicus between 22 June 2023 and 11 July 2024 with no date or language limitations. Full economic evaluations of any postpartum intervention for prevention, detection, or management of PPH were eligible. Study screening, data extraction, and quality assessments (using the CHEC-E tool) were undertaken independently by at least 2 reviewers. We developed narrative syntheses of available evidence for each intervention. From 3,993 citations, 56 studies were included: 33 studies of preventative interventions, 1 study assessed a diagnostic method, 17 studies of treatment interventions, 1 study comparing prevention and treatment, and 4 studies assessed care bundles. Twenty-four studies were conducted in high-income countries, 22 in upper or lower middle-income countries, 3 in low-income countries, and 7 studies involved countries of multiple income levels. Study settings, methods, and findings varied considerably. Interventions with the most consistent findings were the use of tranexamic acid for PPH treatment and using care bundles. In both cases, multiple studies predicted these interventions would either result in better health outcomes and cost savings, or better health outcomes at acceptable costs. Limitations for this review include that no ideal setting was chosen, and therefore, a transferability assessment was not undertaken. In addition, some sources of study uncertainty, such as effectiveness parameters, were interrogated to a greater degree than other sources of uncertainty. Conclusions: In this systematic review, we extracted, critically appraised, and summarised the cost-effectiveness evidence from 56 studies across 16 different interventions for the prevention, diagnosis, and treatment of PPH. Both the use of tranexamic acid as part of PPH treatment, and the use of comprehensive PPH bundles for prevention, diagnosis, and treatment have supportive cost-effectiveness evidence across a range of settings. More studies utilizing best practice principles are required to make stronger conclusions on which interventions provide the best value. Several high-priority interventions recommended by World Health Organization (WHO) such as administering additional uterotonics, non-pneumatic anti-shock garment, or uterine balloon tamponade (UBT) for PPH management require robust economic evaluations across high-, middle-, and low-resource settings.

27 April 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
SSSaima Sultana
Saima Sultana
SASadia Afrin
Sadia Afrin
MHMahamudul Hasan
Mahamudul Hasan
AAAdnan Ansar
Adnan Ansar
KSKM Saif-Ur-Rahman
KM Saif-Ur-Rahman
Objective To assess the diagnostic accuracy of stool specimens to diagnose pulmonary tuberculosis (PTB) in adults. Design Systematic review. Data sources MEDLINE (Ovid), Embase (Ovid), Web of Science and the Cochrane database were searched from inception to 9 March 2023–10 March 2023 using a comprehensive search strategy; reference lists of selected articles and relevant review articles were manually searched. Eligibility criteria for selecting studies Studies in English reporting diagnostic performance of stool specimens against respiratory specimens using mycobacterial culture or smear microscopy or Xpert assay to diagnose PTB in adults were eligible for this systematic review. Data extraction and synthesis Two reviewers independently screened the retrieved citations and extracted data. The risk of bias and applicability of results were assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Narrative data synthesis was performed. Results A total of 1658 citations were screened, and 28 full-text articles were assessed. Nine studies met the inclusion criteria. The reported sensitivity and specificity of stool culture varied between 21.4% and 63.9%, and 61.5% and 100%, respectively. In stool smear microscopy, sensitivities and specificities ranged from 12.1% to 53.9%, and from 79.5% to 100%, respectively. The reported sensitivities of PCR assays, including Xpert assays, ranged from 69.7% to 100%, with specificities ranging from 69.8% to 100%. Most of the studies had a low risk of bias and a low applicability concern in all domains. Conclusion This systematic review could not conclude on the diagnostic accuracy of stool specimens for PTB diagnosis in adults. Further studies are required to evaluate the accuracy of stool specimens in adults to enable meta-analyses in updates of this review as well as other systematic reviews. PROSPERO registration number CRD42021245203.

18 August 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
SSSaima Sultana
Saima Sultana
AAAdnan Ansar
Adnan Ansar
KSKM Saif-Ur-Rahman
KM Saif-Ur-Rahman
Introduction: Tuberculosis (TB) continues to be a significant health burden, most commonly affecting the lungs and referred to as pulmonary TB (PTB). Diagnostic techniques of PTB primarily rely on expectorated sputum samples. However, the diagnostic yields are often hindered due to insufficient volume and quality of the sputum specimens. Moreover, some individuals are unable to provide sputum samples due to scanty sputum production or difficulty in coughing up and require an invasive procedure to obtain a respiratory sample, such as bronchoscopic or gastric aspiration. Thus, challenges in the acquisition of respiratory specimens warrant an alternate specimen. Therefore, this systematic review aims to evaluate the diagnostic accuracy of a stool specimen for the diagnosis of PTB in adults. Methods and analysis: We will search MEDLINE (Ovid), Embase (Ovid), Web of Science and Cochrane database from inception to April 2021 using a comprehensive search strategy. Two reviewers will independently perform screening, data extraction and quality assessment. The risk of bias assessment and applicability of results of eligible studies will be performed using the Quality of Diagnostic Accuracy Studies-2 tool. Bivariate random-effects models will be performed to calculate pooled sensitivity, specificity, positive likelihood ratio and negative likelihood ratio and diagnostic odds ratio along with 95% CI of stool specimen for each reported diagnostic method against any of the reference standard test (ie, mycobacterial culture or smear microscopy or Xpert assay using respiratory specimens). Heterogeneity between studies will be assessed by I 2 statistics and Q statistic of the χ 2 test. Ethics and dissemination: The results will be disseminated through publishing in a peer-reviewed medical journal and public presentations in relevant national and international conferences. As this is a systematic review of publicly available data, ethics approval is not required. PROSPERO registration number: CRD42021245203.

7 May 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
SSSaima Sultana
Saima Sultana
FBFiona Bruinsma
Fiona Bruinsma
ZFZeshi Fisher
Zeshi Fisher
CHCaroline S. E. Homer
Caroline S. E. Homer
JVJoshua P. Vogel
Joshua P. Vogel
Antenatal corticosteroids (ACS) is a critical preterm birth intervention that reduces neonatal mortality and short-term morbidities when administered to women at risk of preterm birth <34 weeks’ gestation. While numerous systematic reviews have evaluated the effects of ACS on child health outcomes, this body of evidence has not been comprehensively assessed. This overview of systematic reviews thus aimed to comprehensively summarize the findings on the effects of ACS for preterm birth on long-term outcomes in children. We searched six electronic databases, with no date and language restrictions. Systematic reviews of randomized, non-randomized trials or observational studies that evaluated childhood health outcomes (assessed at age 12 months or older) for any ACS exposure compared to no ACS exposure, including comparisons between different types and regimens of ACS were eligible. We used the AMSTAR-2 tool to assess the quality of the included reviews. We included 19 systematic reviews. We identified a wide range of outcomes across the included reviews and categorized them as neurodevelopmental, psychological, physical growth, respiratory, cardiovascular, and survival/mortality outcomes. The reported outcomes were substantially varied in terms of operational definitions, terminology, timing of assessment, and measurement. No benefits or harms were observed for most of the reported outcomes following ACS exposure, though many outcomes had few participants. Available evidence suggested that a single course of ACS possibly has positive effects on selected neurodevelopmental outcomes. However, ACS exposure might also have adverse effects on psychological and some neurodevelopmental outcome in children born at late preterm or at term. Heterogeneity in outcome measurements and reporting, including overall confidence in results, contributes to uncertainties about long-term effect of ACS and warrants caution while interpreting the findings. Further high-quality research is required to generate robust evidence base on the effects of ACS on long-term child health outcomes.

2 August 2023 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
SSSaima Sultana
Saima Sultana
JVJoshua P. Vogel
Joshua P. Vogel
OOOlufemi T. Oladapo
Olufemi T. Oladapo